Back to search
HİDRADENİTİS SUPPURATİVA
Clinical trial pipeline · Data from ClinicalTrials.gov
See which HİDRADENİTİS SUPPURATİVA trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which HİDRADENİTİS SUPPURATİVA trials you may qualify forThe purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidradeni…
Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.
This is a multinational, randomized, double-blind, placebo-controlled, Phase 2, dose finding study to evaluate the efficacy and safety of different doses of SAR…
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease p…
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
The purpose of this study is to learn about the safety and effects of the study medicine (called Ritlecitinib) for the possible treatment of hidradenitis suppur…
The purpose of the study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (H…
This is a study to evaluate the long-term safety, tolerability, and efficacy of sonelokimab in participants with moderate to severe hidradenitis suppurativa who…